top of page
Home
Our Science
Our Clinical Trial
The KTX-1001 Program
Expanded Access Policy
About Us
Leadership
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Investors
News & Events
Press Releases
Contact Us
More
Use tab to navigate through the menu items.
Our Leadership
Terry Connolly, Ph.D.
President, Chief Executive Officer, K36 Board Member
Soo Bang
SVP, Strategy and Operations
Chad Lewis, Ph.D.
Senior Director of Chemistry and Manufacturing
Sanjana Umarale Miskin
Director of Clinical Science
Michelle Kim
Business Operations Coordinator
bottom of page
.png)
